Concept:
The clinical picture of widespread diffuse pain, tender "joints" (usually tender points in muscles/tendon insertions), significant fatigue, and unrefreshing sleep, entirely lacking any objective signs of joint swelling, erythema, or systemic inflammation (normal acute phase reactants), is highly suggestive of Fibromyalgia.
Explanation:
• Fibromyalgia is a clinical diagnosis. While basic labs (like TSH, ESR, CBC) are often drawn to exclude other causes (hypothyroidism, inflammatory diseases), extensive immunologic testing or imaging is not required if the history and physical exam are classic and lack "red flags."
• The American College of Rheumatology (ACR) criteria for fibromyalgia (2010/2016 revisions) relies entirely on patient-reported symptom scales: the Widespread Pain Index (WPI) and the Symptom Severity (SS) scale, replacing the older reliance on the 18 specific tender points exam.
• Option (B), RF and anti-CCP testing, is unhelpful and potentially misleading here. Up to 5% of the healthy population may have a low-titer positive RF. In the absolute absence of objective joint swelling (synovitis), testing for RA is not indicated as the pre-test probability for active RA is zero, and a false positive could lead to incorrect, toxic treatments.
• Option (C), MRI of affected joints, is unnecessary. There is no peripheral structural damage or inflammation in fibromyalgia.
• Option (D), Muscle biopsy, is an invasive procedure used to diagnose inflammatory myopathies (polymyositis, dermatomyositis) which present with prominent painless muscle weakness, not widespread pain and tender points.
Final answer:
Because the presentation perfectly matches the symptom complex of fibromyalgia without signs of inflammatory arthritis, the next best step is to formally apply the clinical diagnostic criteria for fibromyalgia.